BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12360742)

  • 1. [Gaucher's and Fabry's diseases: biochemical and genetic aspects].
    Caillaud C; Poenaru L
    J Soc Biol; 2002; 196(2):135-40. PubMed ID: 12360742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.
    Mistry PK; Cox TM
    J Med Genet; 1993 Nov; 30(11):889-94. PubMed ID: 8301642
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.
    Mechtler TP; Stary S; Metz TF; De Jesús VR; Greber-Platzer S; Pollak A; Herkner KR; Streubel B; Kasper DC
    Lancet; 2012 Jan; 379(9813):335-41. PubMed ID: 22133539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
    Alfonso Palacín P; Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha-galactosidase A (GLA) enzymes.
    Squillaro T; Antonucci I; Alessio N; Esposito A; Cipollaro M; Melone MAB; Peluso G; Stuppia L; Galderisi U
    J Cell Physiol; 2017 Dec; 232(12):3454-3467. PubMed ID: 28098348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis of Gaucher's disease.
    Mistry PK; Smith SJ; Ali M; Hatton CS; McIntyre N; Cox TM
    Lancet; 1992 Apr; 339(8798):889-92. PubMed ID: 1348297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; Gaucher disease].
    Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
    Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
    Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
    Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
    Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects].
    Germain DP
    J Soc Biol; 2002; 196(2):161-73. PubMed ID: 12360745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.
    Cormand B; Grinberg D; Gort L; Chabás A; Vilageliu L
    Hum Mutat; 1998; 11(4):295-305. PubMed ID: 9554746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of genotyping in Fabry's disease].
    Froissart R; Piraud M; Maire I
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S275-8. PubMed ID: 21211679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of 28 Gaucher disease patients: the Australasian experience.
    Lewis BD; Nelson PV; Robertson EF; Morris CP
    Am J Med Genet; 1994 Jan; 49(2):218-23. PubMed ID: 8116672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease.
    Tse KC; Chan KW; Tin VP; Yip PS; Tang S; Li FK; Ho YW; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jan; 18(1):182-6. PubMed ID: 12480979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
    Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
    Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
    Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
    Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.
    Tayebi N; Callahan M; Madike V; Stubblefield BK; Orvisky E; Krasnewich D; Fillano JJ; Sidransky E
    Mol Genet Metab; 2001 Aug; 73(4):313-21. PubMed ID: 11509013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.